Clinical Trial Update: Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult Patients [Phase 2]

View source ↗

Summary

A Phase 2 efficacy trial of FANG(30) in adults with active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• FANG(30) (FANG(30))

Snippet

Sponsor: Juan C. Bertoglio, MD | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED